Pentoxifylline as an adjunct therapy in children with cerebral malaria

Background. Pentoxifylline (PTX) affects many processes that may contribute to the pathogenesis of severe malaria and it has been shown to reduce the duration of coma in children with cerebral malaria. This pilot study was performed to assess pharmacokinetics, safety and efficacy of PTX in African c...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Lell, B, Köhler, C, Wamola, B, Olola, C, Kivaya, E, Kokwaro, G, Wypij, D, Mithwani, S, Taylor, T, Kremsner, P, Newton, C
Μορφή: Journal article
Γλώσσα:English
Έκδοση: BioMed Central 2010

Παρόμοια τεκμήρια